Gencurix, Inc., a Korea based company dedicated in development and market of innovative molecular diagnostics, has annou...
South Korea’s plans to invest more than US$1.7bn in its biotechnology and biopharmaceutical sectors over the next ...
SillaJen, Inc., a South Korea based clinical-stage, biotherapeutics company focused on the development of oncolytic immu...
Already home to more than 40 pharmaceutical multinationals, Korea is on course to become a global biotech and pharmaceut...
South Korea headquartered Samsung BioLogics (SBL) and Belgium based biopharmaceutical company UCB have agreed to an addi...
Mezzion Pharma Co. Ltd., a biotech company based in Korea, haas announced that top line data from the Phase 3 Fonta...
LISCure Biosciences, a South Korea based biotech company that researches and develops bacteria-mediated immunotherapy, h...
Samsung Bioepis becomes the first company to receive FDA approvals for biosimilars referencing all three first-generatio...
Shinsung TK, a Korean company specializing in security system based on IoT (Internet of Things) technology, has become v...
South Korea based Orum Therapeutics has announced an oversubscribed $30 million Series B financing. New investors, ...
The company also supported a recent HeForShe movement sponsored by the city of Jechoen. HeforShe is an UN-led gender equ...
Janssen Korea Ltd. and Johnson & Johnson Innovation LLC, on 17 July 2019, announced the launch of the Seoul Innovati...
Contera Pharma, a Danish subsidiary of South Korea based Bukwang Pharmaceutical, has attracted 3 billion won in Series A...
Yuyu Pharma, a Korean pharmaceutical company celebrated its third year of implementing Yuyu's compliance management syst...
Daewoong Pharmaceutical Co., Ltd, a world-leading botulinum toxin manufacturer in Korea, announced its participation in ...
Bridge Biotherapeutics, a South Kprea based clinical-stage biotech company, which aims to develop novel therapeutics for...
Boehringer Ingelheim and Yuhan Corporation have announced a collaboration and license agreement for the development of a...
BNO BIO, a joint venture between South Korea based Bukwang Pharm and OCI, has invested in overseas biotech venture compa...
